TY - JOUR
T1 - From association to causality
T2 - The new frontier for complex traits
AU - Katsanis, Elias Nicholas
N1 - Funding Information:
I thank Sara Katsanis and Erica Davis for helpful discussion and editing of the manuscript. This work was supported by grants R01HD04260 from the National Institute of Child Health and Development, R01DK072301 and R01DK075972 from the National Institute of Diabetes, Digestive, and Kidney disorders and P20MH084018 from the National Institute of Mental Health.
PY - 2009/2/25
Y1 - 2009/2/25
N2 - Technological and analytical advances have led to an unprecedented catalog of genomic regions associated with a broad range of clinically relevant phenotypes in humans. However, some examples notwithstanding, the causes of the overwhelming majority of genetic diseases remain obscure. More importantly, an emerging lesson from genome-wide association studies is that, in most instances, the resolution necessary for identifying actual genes that underlie the phenotype is limited, as is our ability to develop mechanistic, testable disease models from such studies. These new realities will probably necessitate a paradigm shift in our approach to complex traits, for which the combinatorial application of genomic and functional studies will be necessary to understand the mechanism and pathology of genetic disease. Here I will discuss these issues and highlight how additional sequencing and genotyping of ever-increasing cohort sizes without functional interpretation is unlikely to improve our ability to dissect the genetic basis of complex traits.
AB - Technological and analytical advances have led to an unprecedented catalog of genomic regions associated with a broad range of clinically relevant phenotypes in humans. However, some examples notwithstanding, the causes of the overwhelming majority of genetic diseases remain obscure. More importantly, an emerging lesson from genome-wide association studies is that, in most instances, the resolution necessary for identifying actual genes that underlie the phenotype is limited, as is our ability to develop mechanistic, testable disease models from such studies. These new realities will probably necessitate a paradigm shift in our approach to complex traits, for which the combinatorial application of genomic and functional studies will be necessary to understand the mechanism and pathology of genetic disease. Here I will discuss these issues and highlight how additional sequencing and genotyping of ever-increasing cohort sizes without functional interpretation is unlikely to improve our ability to dissect the genetic basis of complex traits.
UR - http://www.scopus.com/inward/record.url?scp=77953431670&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953431670&partnerID=8YFLogxK
U2 - 10.1186/gm23
DO - 10.1186/gm23
M3 - Comment/debate
C2 - 19341494
AN - SCOPUS:77953431670
SN - 1756-994X
VL - 1
JO - Genome Medicine
JF - Genome Medicine
IS - 2
M1 - gm23
ER -